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Abstract Artificial pancreas (AP) systems have shown to improve glucose regu-
lation in type 1 diabetes (T1D) patients. However, full closed-loop performance
remains a challenge particularly in children and adolescents, since these age groups
often present the worst glycemic control. In this work, an algorithm based on
switched control and time-varying insulin-on-board (IOB) constraints is presented.
The proposed control strategy is evaluated in silico using the FDA-approved UVA/
Padova simulator and its performance contrasted with the previously introduced
Automatic Regulation of Glucose (ARG) algorithm in the pediatric population.
The effect of unannounced meals is also explored. Results indicate that the pro-
posed strategy achieves lower hypo- and hyperglycemia than the ARG for both
announced and unannounced meals.
Keywords Artificial pancreas · Switched control · Insulin on board · Constrained
control
1 Introduction
Artificial pancreas (AP) systems consist of a subcutaneous insulin pump connected
to a continuous glucose monitoring (CGM) sensor through a control algorithm
that automatically calculates insulin doses according to CGM measures [1]. Un-
fortunately, the subcutaneous route introduces considerable issues, including large
delays in glucose measurement and insulin action [2].
The vast majority of AP systems are based on model predictive control (MPC)
[3–5] , proportional-integral-derivative (PID) [6–8] and fuzzy logic (FL) [9] (see [10]
for a thorough description of the current situation). Since high model uncertainty
and large delays limit the autonomy of the glucose controller, most of these control
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systems are hybrid, i.e., a combination of manual meal boluses and a control
algorithm that adjusts basal infusion. However, carbohydrates (CHO) counting
implies an important burden and risk for people with diabetes [11].
Fig. 1 Glycemia (mean ± 1 std) vs time of the three age ranges available in the UVA/Padova
simulator when facing 5 meals during 36 hs using the ARG controller (10 adults - red, 10
adolescents - yellow, 10 children - cyan). Dashed green lines delimit the desired range ([70-180]
mg/dl) and the yellow show the acceptable range ([70-250] mg/dl).
Recently, a control algorithm without pre-meal insulin boluses called Auto-
matic Regulation of Glucose (ARG) was proposed and clinically evaluated in
adult subjects with type 1 diabetes (T1D) at the Hospital Italiano de Buenos
Aires (HIBA) [12,13]. This algorithm consists of an inner switched linear quadratic
gaussian (SLQG) controller and an outer sliding mode safety layer called Safety
Auxiliary Feedback Element (SAFE) [14]. The inner controller switches between
an aggressive LQG controller to compensate for the effect of meals and other large
perturbations, and a conservative LQG controller to maintain euglycemia at all
other times [13]. A meal announcement is required at meal times to trigger a lis-
tening mode in which the controller waits to detect an increasing trend on CGM
readings to switch to the aggressive controller. Although promising results were
obtained, more intensive trials are necessary to assess the controller performance.
Particularly, trials involving children and adolescents are fundamental since these
age groups often present poor glycemic control and respond to treatment signifi-
cantly different from adults. To this end, a clinical trial in collaboration with the
pediatric hospital Garrahan in Buenos Aires is expected to take place in 2020.
Figure 1 shows the response of the different age groups available in the UVA/Padova
simulator to a 5 meal scenario similar to the one carried out at the HIBA using the
ARG algorithm. It can be seen that children and adolescents present larger glucose
excursions and more pronounced hypo- and hyperglycemic episodes. Therefore, it
is reasonable to consider an enhanced control approach in order to control the
pediatric population.
Additionally, the pediatric population presents other obstacles concerning glycemic
control. Children and adolescents are more prone to forget to announce meals and
to suffer from diabetic burnout [15]. Therefore, an unannounced meal strategy
would particularly benefit this age group. AP systems that do not require any kind
of meal announcement involving both single-hormone [16,17] and dual-hormone
[18] therapy have been proposed and tested in the adult population. Particularly,
an in silico study evaluating the performance of the ARG algorithm with unan-
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nounced meals was made [19]. This work introduced an automatic switching signal
generator (SSG), which commanded the switching between aggressive and conser-
vative controllers, thus eliminating the listening mode. Even though encouraging
results were achieved, the study was only a preliminary evaluation considering the
adult population. To the extent of the authors knowledge, no single-hormone full
closed-loop AP system has been tested in children or adolescents.
In this paper, a further step on the ARG algorithm is given, aiming to be
tested in vivo in the Garrahan clinical trials. The proposed controller takes ad-
vantage of the ARG algorithm switched strategy (SLQG), while introducing a
redesigned switching logic and time-varying IOB constraints. This kind of con-
straint is called Amplitude Enable (AE) and allows the controller to act more ag-
gressively at the beginning of the meal without risking postprandial hypoglycemia
[20]. The proposed control strategy (ARGAE) is then evaluated in silico using
the FDA-approved UVA/Padova simulator and contrasted to the ARG algorithm.
Simulation scenarios involving unannounced meals are also explored using the SSG
mentioned above.
2 Materials and Methods
In this section, the ARG algorithm, the automatic SSG and the proposed ARGAE
are described.
2.1 The ARG Algorithm
Fig. 2 Block diagram of the ARG and ARGAE algorithms
The ARG algorithm regulates glycemia without delivering open-loop prandial
boluses. Figure 2 shows a block diagram of the ARG algorithm and the ARGAE
algorithm, highlighting with fill boxes the new components of the latter. The
main controller is an SLQG, which switches between an aggressive controller K2,
which is in charge of compensating for the effects of the meals, and a conservative
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controller K1, which maintains glucose levels in the desired range during fasting
periods [13]. The output of this block is the insulin dose calculated by the SLQG
(uc).
Since the controller does not have integral action, the open-loop basal insulin
is added to uc, yielding u. The signal u would command the insulin pump if the
SAFE layer was not present. However, the SAFE shapes u through the signal γ
(γ ∈ [0, 1]) in order to avoid violating an imposed restriction on the insulin-on-
board (IOB). Therefore, the insulin dose that is finally delivered to the patient is
γu.
For the HIBA clinical trials, the switching from K1 to K2 was made using
a meal announcement. The announcement triggered a listening mode where the
algorithm waited to detect an increasing trend on CGM readings to switch to K2.
It is worth highlighting that the meal announcement was not used to deliver meal
priming boluses and no CHO counting was required. Instead, the user informed
the size of the meal using one of three categories: small, medium and large. This
information was used to tune the SAFE layer (see equation (1) below). On the
other hand, the switching form K2 to K1 occurred automatically after one hour.
The SAFE layer in the ARG algorithm uses piecewise constant IOB constraints
depending on the announced meal classification, according to the following equa-
tions:
– Small meals < 35 gCHO:
IOB = IOBss + 40 gCHO/CR,
– Medium meals [35, 65) gCHO:
IOB = IOBss + 55 gCHO/CR, (1)
– Large meals ≥ 65 gCHO:
IOB = IOBss + 70 gCHO/CR,
where IOBss is the IOB with the basal insulin infusion, and CR is each patients
carbohydrate ratio.
The ARG algorithm has been validated in vivo in adult patients at the HIBA
clinical trial. Although results were encouraging, in silico evaluation showed that
the performance worsened when controlling the pediatric population. As shown in
figure 1, hyper- and hypoglycemia are more prominent for children and adolescents
than for adults.
2.2 Switching Signal Generator (SSG)
Fig. 3 Block diagram of the meal detection algorithm.
The signal that commands when the ARG algorithm is triggered into its aggres-
sive mode is σ. In order to eliminate the need for announcing the meal manually,
a meal detection algorithm to establish σ based on CGM readings was proposed
in [19].
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Figure 3 shows a block diagram of the proposed meal detector. The first block
is a noise spike filter (NSF) that limits the maximum BG rate of change to 3
mg/dl/min [21]. The filtered signal gf is the input to the second block, which is
a Kalman filter. The Kalman filter is used to estimate the amount of glucose in
the first phase of the stomach Q̂sto1 [22]. The Switching Signal block determines
whether a meal is present or not using predefined thresholds for gf and Q̂sto1. See
[19] for further details on the SSG.
2.3 The ARG Algorithm with Amplitude Enable (ARGAE)
According to [23], the theoretically optimal treatment for glucose regulation is the
basal-superbolus open-loop therapy. However, the high uncertainty present in meal
size and composition, patient parameters, and sensor readings make closed-loop
control highly convenient. With this in mind, an IOB limitation strategy based on
open-loop therapy was introduced, called the AE [20].
The AE block uses sliding mode control in order to avoid the violation of an
imposed restriction. In this case, the restriction is time-varying, shaped as the
open-loop therapy IOB profile multiplied by a constant β > 1, in order to give
the controller an extra degree of freedom. Figure 4 shows the IOB constraint for
different values of β.
Fig. 4 IOB for different values of β
The AE layer, can work around any main controller. Here, it is combined with
a switched strategy (the ARG algorithm SLQG), since using a very aggressive
controller at all times might generate undesired oscillations, and a conservative one
might not be strong enough to compensate large perturbations like meal intake.
In order to further reduce hyperglycemia risk, IOB is set to never be less
than two times IOBss. Additionally, the switching policy between K1 and K2 is
redesigned: the commutation from conservative to aggressive is made immediately
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after a meal is announced or detected. Then, the controller switches from aggressive
to conservative only when a decreasing trend (three consecutive samples) in CGM
readings is observed.
When meals are announced, meal classification is used in order to compute the
IOB. When meals are automatically detected, a medium-sized meal is assumed.
An illustrative example of the ARG and the ARGAE insulin infusion and IOB
profiles when facing a meal is shown in figure 5. Since for the SAFE layer IOB is a
constant piecewise function, insulin delivery is lower than with the ARGAE at meal
intake, and close to basal values in the postprandial period. On the other hand,
it can be seen that the insulin response generated by the ARGAE is similar to a
superbolus: large insulin spikes at meal time, followed by a cut in basal insulin
delivery. The shape of the IOB constraint used for the AE has the advantage
of allowing large insulin doses at the beginning of the meal, and reducing them
gradually as the meal effect ends. The AE allows this non-linear behaviour to
an otherwise linear controller like the LQG, which is a distinctive feature of the
proposal.
Fig. 5 Example of the IOB, IOB and resulting insulin dose for the ARG with the SAFE layer
(red) and for the ARGAE (blue).
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3 Results
In this section, results from in silico tests are shown. First, the ARG with the
amplitude enable layer (ARGAE) is evaluated considering a medium-sized meal
for different values of β using the adolescent and children age groups available in
the UVA/Padova simulator. The results are compared to the ARG and a retuned
ARG (ARG80%), in which the IOB is reduced to %80 of the value obtained using
(1) in order to reduce frequency of hypoglycemia episodes. The meal is announced
at the time of intake, with the appropriate meal classification (medium).
Fig. 6 Penalty index: weight vs. glucose concentration
Then, according to the first set of simulations, an adequate value for β is
selected. To this end, a performance index based on hyper- and hypoglycemia
risk is used [3,24]. Figure 6 shows the weigth vs. glycemia used to compute this
index. As it can be observed, this index penalizes values outside the desired range.
Hypoglycemia is more heavily penalized as it can present the most dangerous
consequences. It can be seen from the function shape that a low index is desired.
For the second set of simulations, meal size error is considered using a small
and a large-sized meal while announcing a medium meal.
Lastly, the same scenarios are simulated without the use of meal announcement.
For all the different ARG configurations, a medium size meal is assumed whenever
a meal is detected.
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For all simulations, meal intake takes place at t = 1 and is followed by a 9 hour
post-prandial observation period. CGM noise is also considered using a DEXCOM
CGM model.
3.1 in silico evaluation with announced meals
Here, the results from the simulation sets using meal announcement are shown
and analyzed.
3.1.1 Medium-sized meal - β sweep
Table 1 Results (% of time) for the 10 adolescents of the UVA/Padova Simulator using
the ARG, ARG80% and ARGAE with different values of β. Meal size: 55 gCHO (medium).










Hyperglycemia 23.1 +-4.2 27.2 +-4.8 22.5 +-4.4 22.0 +-4.3 21.5 +-4.3
Hypoglycemia 1.0 +-3.2 0.0 +-0.0 0.0 +-0.0 0.0 +-0.0 0.5 +-1.7
Severe hyperglycemia 11.7 +-5.8 13.7 +-6.0 10.7 +-6.5 10.5 +-6.4 10.3 +-6.3
Desired range 75.9 +-6.5 72.8 +-4.8 77.5 +-4.4 78.0 +-4.3 77.9 +-4.4
Acceptable range 87.3 +-7.8 86.3 +-6.0 89.3 +-6.5 89.5 +-6.4 89.2 +-6.9
Penalty Index 7.13 7.70 6.51 6.50 6.65
Table 1 shows the mean ± 1 std of the % time in hyperglycemia (>180mg/dl),
hypoglycemia (<70mg/dl), severe hyperglycemia (>250mg/dl), the desired range
(70-180mg/dl) and the acceptable range (70-250mg/dl) for the 10 adolescents
available in commercial version of the UVA/Padova simulator using the ARG,
the ARG80% and the ARGAE for a 55 gCHO meal. It can be observed that while
the ARG80% reduces hypoglycemia, it significantly increases time spent in hy-
perglycemia, thus achieving a higher penalty index than the ARG. On the other
hand, ARGAE achieves the same reduction of hypoglycemia episodes, while also
diminishing hyperglycemia when an adequate β is selected. In this case, a β = 1.4
achieves the most time in the desired and acceptable ranges and the lowest penalty
index (grey column).
Figure 7 shows the glucose, insulin infusion, controller mode and IOB over time
for the ARG and the ARGAE with β = 1.4 for adolescent #004 of the UVA/Padova
simulator. As expected, the ARGAE administers larger doses of insulin at the be-
ginning of the meal and cuts insulin afterwards, slowly returning to basal delivery
when BG values start to decrease. On the other hand, the constant IOB in the ARG
results in a more distributed insulin dosage by the end of the meal. This causes a
larger hyperglycemia peak with a higher risk of postprandial hypoglycemia. Thus,
it can be observed that the ARGAE generates a slightly lower peak in BG than
the ARG, while achieving safer postprandial BG values.
Table 2 shows the same metrics as table 1 but for the 10 children available in
the UVA/Padova simulator, also for the ARG, the ARG80% and the ARGAE with
different values of β. In this case, the ARGAE and the ARG80% show significant
reduction in the time in hypoglycemia compared to the ARG. However, ARG80%
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Fig. 7 Glucose, insulin, controller mode (1 - aggressive, 0 - conservative) and IOB evolution
over time of adolescent 4 of the UVA/Padova simulator using the ARG (solid red) and the
ARGAE with β = 1.4 (dashed-dotted black).
shows a pronounced increase in hyperglycemia . Additionally, time in range is
significantly improved by the ARGAE .
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Table 2 Results (% of time) for the 10 children of the UVA/Padova Simulator using the ARG,











Hyperglycemia 19.9 +-3.3 24.2 +-4.8 21.1 +-4.4 20.6 +-4.2 19.7 +-3.8
Hypoglycemia 6.0 +-8.8 0.0 +-0.0 0.5 +-1.7 1.5 +-3.3 3.1 +-5.7
Severe hyperglycemia 12.8 +-4.5 15.7 +-4.7 12.6 +-5.3 12.3 +-5.2 11.9 +-5.0
Desired range 74.0 +-7.1 75.8 +-4.8 78.3 +-4.7 77.9 +-4.6 77.2 +-5.4
Acceptable range 81.1 +-8.3 84.3 +-4.7 86.9 +-6.0 86.2 +-6.6 85.1 +-7.9
Penalty Index 11.98 9.65 7.89 7.86 8.90
The results for both children and adolescents using the ARG80% show that even
though hypoglycemia can be reduced, it is in exchange of a significant increase in
hyperglycemia and severe hyperglycemia.
3.1.2 Overestimated announced meal
Here, a 40 gCHO (small) meal is considered but a medium meal is announced in
order to evaluate the algorithms performance when meals are overestimated.
Table 3 Results (% of time) for the 10 adolescents of the UVA/Padova Simulator using the




Hyperglycemia 17.7 +-4.2 16.7 +-4.3
Hypoglycemia 4.4 +-9.3 3.5 +-6.2
Severe hyperglycemia 4.1 +-5.6 3.8 +-5.3
Desired range 77.9 +-10.6 79.8 +-6.6
Acceptable range 91.5 +-10.6 92.7 +-7.7
Penalty Index 5.62 4.23
Table 3 shows the same metrics as table 1 for the 10 adolescents available
in the UVA/Padova simulator using the ARG and the ARGAE with β = 1.4.
Since the meal is overestimated, the time spent in hyperglycemia is lower for
all control strategies compared with the 55 gCHO meal. Also, hypoglycemia is
increased for the ARG. On the other hand, hypoglycemia is reduced with the
ARGAE , while slightly lowering time in hyperglycemia. If a more conservative β
had been chosen in order to prioritize hypoglycemia prevention, hypoglycemia can
be further reduced using the ARGAE , For example, with β = 1.35: % time in
hyperglycemia = 17.0 ± 4.3, hypoglycemia = 1.4 ± 3.6, severe hyperglycemia =
3.8 ± 5.4, the desired range = 81.6 ± 5.1 and the acceptable range = 94.8 ± 6.0,
yielding an index of 3.76.
Table 4 shows the same metrics as table 3 but for the 10 children available in
the UVA/Padova simulator, also for the ARG and the ARGAE with β = 1.25 based
on the results form 3.1.1. In this case, the ARG and the ARGAE show the same
% of time in hyperlgycemia, while obtaining similar hypoglycemia. However, like
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Table 4 Results (% of time) for the 10 children of the UVA/Padova Simulator using the ARG




Hyperglycemia 15.7 +-3.2 15.2 +-3.4
Hypoglycemia 6.8 +-9.0 7.2 +-10.2
Severe hyperglycemia 7.4 +-3.9 6.4 +-4.0
Desired range 77.6 +-7.1 77.6 +-8.0
Acceptable range 85.9 +-8.8 86.4 +-10.1
Penalty Index 9.39 7.95
with the adolescent age group, if a more restrictive β were selected, the ARGAE
has the ability of reducing hypoglycemia while maintaining low hyperglycemia.
For example, with β = 1.15: % time in hyperglycemia = 16.2± 3.7, hypoglycemia
= 2.9± 4.4, severe hyperglycemia = 6.9± 4.1, the desired range = 80.9± 2.6 and
the acceptable range = 90.2± 4.8, yielding an index of 5.24
3.1.3 Underestimated announced meal
Here, a 70 gCHO (large) meal is considered but a medium meal is announced in
order to evaluate the algorithms performance when meals are underestimated.
Table 5 Results (% of time) for the 10 adolescents of the UVA/Padova Simulator using the




Hyperglycemia 27.8 +-4.2 26.5 +-4.5
Hypoglycemia 0.0 +-0.0 0.0 +-0.0
Severe hyperglycemia 17.9 +-4.6 16.8 +-4.8
Desired range 72.2 +-4.2 73.5 +-4.5
Acceptable range 82.1 +-4.6 83.2 +-4.8
Penalty Index 10.94 10.15
Table 5 shows the same metrics as table 1 for the 10 adolescents available in the
UVA/Padova simulator using the ARG and the ARGAE with β = 1.4. Since the
meal is underestimated, the time spent in hyperglycemia is higher for both control
strategies, and hypoglycemia is avoided. On the other hand, hyperglycemia and
severe hyperglycemia are slightly improved with the ARGAE , thus achieving the
lowest index.
Table 6 shows the same metrics as table 5 but for the 10 children available in the
UVA/Padova simulator, also for the ARG and the ARGAE with β = 1.25. In this
case, hyperglycemia is increased when using the ARGAE . However, hypoglycemia
is avoided with the ARGAE , which is the primary goal specially when regulating
BG in children since it can have the most severe consequences. Additionally, as
with adolescents, the lowest penalty index is achieved with the ARGAE .
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Table 6 Results (% of time) for the 10 children of the UVA/Padova Simulator using the ARG




Hyperglycemia 24.0 +-3.9 26.0 +-5.6
Hypoglycemia 4.0 +-6.5 0.0 +-0.0
Severe hyperglycemia 17.6 +-3.9 17.8 +-4.3
Desired range 72.0 +-5.5 74.0 +-5.6
Acceptable range 78.3 +-6.1 82.2 +-4.3
Penalty Index 14.74 12.30
3.2 in silico evaluation with unannounced meals
Table 7 Results (% of time) for the 10 adolescents of the UVA/Padova Simulator using the











Hyperglycemia 23.7 +-4.2 27.7 +-4.8 23.8 +-4.1 23.1 +-4.0 22.5 +-4.0
Hypoglycemia 1.7 +-3.7 0.0 +-0.0 0.0 +-0.0 0.0 +-0.0 0.3 +-1.1
Severe hyperglycemia 12.7 +-5.3 14.6 +-5.7 12.5 +-5.3 12.1 +-5.2 11.9 +-5.2
Desired range 74.6 +-6.5 72.3 +-4.8 76.2 +-4.1 76.9 +-4.0 77.2 +-4.0
Acceptable range 85.6 +-7.3 85.4 +-5.7 87.5 +-5.3 87.9 +-5.2 87.8 +-5.5
Penalty Index 7.61 8.06 7.09 7.08 7.31
Table 8 Results (% of time) for the 10 children of the UVA/Padova Simulator using the











Hyperglycemia 20.8 +-3.1 24.6 +-4.2 23.1 +-4.6 22.2 +-4.3 21.1 +-3.9
Hypoglycemia 6.3 +-8.6 1.3 +-4.2 0.0 +-0.0 0.4 +-1.3 4.5 +-6.2
Severe hyperglycemia 14.2 +-3.5 16.8 +-3.9 15.0 +-3.9 14.4 +-3.7 13.9 +-3.7
Desired range 72.9 +-6.9 74.0 +-5.9 76.9 +-4.6 77.4 +-4.5 74.4 +-4.4
Acceptable range 79.5 +-7.6 81.9 +-6.4 85.0 +-3.9 85.1 +-4.3 81.6 +-5.4
Penalty Index 13.23 10.83 9.25 9.08 10.45
Tables 7 and 8 show the mean ± 1 std of the % time in hyperglycemia
(>180mg/dl), hypoglycemia (<70mg/dl), severe hyperglycemia (>250mg/dl), the
desired range (70-180mg/dl) and the acceptable range (70-250mg/dl) for the 10
adolescents available in commercial version of the UVA/Padova simulator using
the ARG, the ARG80% and the ARGAE for a 55 gCHO meal when no meal an-
nouncement is used. As it was demonstrated for the adult population in [19], the
ARG with unannounced meals achieves similar in silico results to the ARG with
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meal announcement. The ARGAE also preserves its performance, but using a dif-
ferent value of β. This is due to the fact that, in section 3.1, the IOB limit is
increased at the time of meal announcement, whereas here it is raised when the
meal is detected (i.e., when glucose values raise). Figure 8 shows this difference in
the IOB constraints.
Fig. 8 IOB and IOB constraint with the ARGAE with meal announcement and the ARGAE
with meal detection.
As was the case with announced meals, the ARGAE presents improved per-
formance compared to both the ARG and ARG80%. The same behaviour is ob-
tained when considering over- (tables 9 and 10) and underestimated meals (tables
11 and 12). If meals are overestimated, the ARG and the ARGAE show similar
performance. However, if a conservative β is selected, hypoglycemia is reduced
while maintaining low hyperglycemia. For example, for the adolescent population
if β = 1.1 is used: % time in hyperglycemia = 18.5±3.9, hypoglycemia = 1.9±6.1,
severe hyperglycemia = 4.4±5.9, the desired range = 79.6±6.7 and the acceptable
range = 93.7± 7.3, yielding an index of 4.49. For underestimated meals, the most
adequate algorithm remains the ARGAE .
Table 9 Results (% of time) for the 10 adolescents of the UVA/Padova Simulator using the




Hyperglycemia 18.7 +-3.9 18.1 +-3.9
Hypoglycemia 5.7 +-9.5 5.1 +-8.7
Severe hyperglycemia 4.5 +-6.0 4.3 +-5.8
Desired range 75.6 +-11.0 76.8 +-10.0
Acceptable range 89.8 +-11.1 90.6 +-9.8
Penalty Index 5.54 5.62
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Table 10 Results (% of time) for the 10 children of the UVA/Padova Simulator using the




Hyperglycemia 16.6 +-2.9 16.9 +-3.2
Hypoglycemia 7.5 +-10.1 6.4 +-8.7
Severe hyperglycemia 8.5 +-3.9 8.5 +-3.9
Desired range 75.9 +-8.1 76.7 +-6.5
Acceptable range 84.1 +-8.9 85.1 +-7.5
Penalty Index 10.75 9.00
Table 11 Results (% of time) for the 10 adolescents of the UVA/Padova Simulator using the




Hyperglycemia 28.1 +-4.1 27.9 +-4.2
Hypoglycemia 1.2 +-3.9 0.0 +-0.0
Severe hyperglycemia 18.4 +-4.4 18.0 +-4.5
Desired range 70.7 +-7.0 72.1 +-4.2
Acceptable range 80.4 +-7.3 82.0 +-4.5
Penalty Index 11.46 10.93
Table 12 Results (% of time) for the 10 children of the UVA/Padova Simulator using the




Hyperglycemia 24.7 +-3.5 27.5 +-5.4
Hypoglycemia 4.6 +-7.2 0.0 +-0.0
Severe hyperglycemia 18.8 +-3.6 19.6 +-4.2
Desired range 70.7 +-6.3 72.5 +-5.4
Acceptable range 76.6 +-6.9 80.4 +-4.2
Penalty Index 16.58 14.11
4 Discussion
Intensive in silico studies show that a simple retune of the IOB is not enough
to achieve satisfactory performance in children and adolescents using the ARG
algorithm. When the meal size is estimated properly, the ARGAE has the ability
of reducing hypoglycemia episodes as was done with the ARG with reduced IOB
constraint but without increasing (or even further lowering) time in hyperglycemia
compared to the ARG. Thus, the compromise between prandial hyperglycemia and
postprandial hypoglycemia is reduced.
When meals are not classified adequately, the ARGAE shows consistent robust
performance in children and adolescents. When meals are overestimated, hypo-
glycemia might not be reduced compared to the ARG if β is too relaxed. However,
β can be as conservative as necessary taking into account individual patient habits,
achieving effective hypoglycemia diminution.
When no meal announcement is used, the ARGAE performance is consistent
with the announced-meal scenario when an adequate value of β is selected, achiev-
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ing the better outcome from both algorithms. However, as expected, for both the
ARGAE and the ARG, time in the desired and the acceptable ranges are reduced
compared with their versions using meal announcement. This is due to the addi-
tional delay in the aggressive controller action introduced by the meal detection
algorithm. Since no meal announcement is used, the algorithm must check ad-
ditional conditions (the ones predefined for gf and Qsto1) in order to verify the
appearance of a meal.
Another important upside of the ARGAE is that its tuning is relative to the
open-loop therapy. This is an advantage since it is more user-friendly, and can use
the information from the traditional patient treatment.
Lastly, it must be kept in mind that no extra protection layers were used in
this in silico study. More tests must be carried out using hypo- and hyperglycemia
protection layers as the ones employed in [12] in order to further improve the
controller performance.
5 Conclusions
A strategy for automatic glycemic regulation based on switched control and time-
varying IOB constraints was introduced and compared with the previously tested
ARG algorithm. The comparison is made in silico considering the pediatric pop-
ulation available in the UVA/Padova simulator, on account of the coming up
clinical trials in children and adolescents. Simulations show that the proposed
algorithm improves the performance of the ARG algorithm and is robust to mis-
classified meals, as well as providing intuitive tuning. The scenario considering
unannounced meals is also explored, accomplishing consistent performance from
the ARGAE . Thus, future in vivo testing of the ARG algorithm will involve the
ARGAE configuration.
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